Durham-based Priovant Therapeutics, with Roivant Sciences, has shared encouraging results from its Phase 3 VALOR study evaluating brepocitinib, a potential new treatment for the autoimmune disease ...

A judge has denied BioMed Realty’s motions to intervene in its bid to recover millions from a tenant over a breached ...

Medpace said late Wednesday that it had $789 million in new orders in the third quarter, up about 49% from the year-ago ...

Eli Lilly and Company’s LLY stock has risen 9.5% in a month, mainly due to the recent recovery in the pharma sector. The drug ...

Ipsen is acquiring next-gen immuno-oncology biotech ImCheck Therapeutics for its investigational cancer combination therapy ...

In recognition of his contributions to viral vector–based therapeutics and translation, Dr. Curiel was elected a Fellow of the National Academy of Inventors. He is also a co-founder of biotech ...

Terns Pharmaceuticals has shelved its oral GLP-1 obesity candidate after a phase 2 trial delivered a mix of weight loss and ...

The prolific company creator is staking $50 million on AI drug discovery for cancer and immune diseases, launching a biotech ...

Chinese drugmaker Innovent Biologics could receive up to US$11.4 billion from a cancer-drug partnership with Japan's Takeda Pharmaceutical, marking the latest in a wave of tie-ups between Chinese ...

Flagship Pioneering spinout Expedition Medicines already has $50 million in capital and a collaboration with Pfizer under its ...

Biotech clinical laboratories are at the center of new medical discoveries, using tools like molecular biology and genetics ...